"Although initially described in Canada, ARSACS has since been reported in other regions of the world, including the Netherlands 9, Brazil 7, Italy 4, France 10, Iran 13, Japan, Turkey and Tunisia 12."
"Although initially described in Canada, ARSACS has since been reported in other regions of the world, including the Netherlands 9, Brazil 7, Italy 4, France 10, Iran 13, Japan, Turkey and Tunisia 12."
"Other clinical features include distal amyotrophy, dysarthria, retinal optic nerve hypermyelination, bowel and bladder dysfunction, and intellectual disability 12,13."
"T2/FLAIR hypointensities in the pons with a characteristic tigroid, linear, striated or striped appearance"